David Ewing Duncan

Co-founder & CEO Arc Programs

davidduncanDavid is a correspondent for The Atlantic and the chief correspondent for NPR Talk’s Biotech Nation. His most recent book is When I’m 164: The new science of radical life extension, and what happens if it succeeds. He also wrote Experimental Man: What One Man’s Body Reveals about His Future, Your Health, and Our Toxic World. David’s most recent venture is Arc, an independent organization on a quest to help shape and accelerate the fusion of bio-medicine with information technologies and big data.